High-dose hypofractionated stereotactic body radiotherapy for spinal chordoma

CONCLUSIONS: Neoadjuvant high-dose, hypofractionated SBRT for spinal chordoma is safe and does not increase surgical morbidities. Early outcomes at 2 years are promising, although long-term follow-up is pending.PMID:34388713 | DOI:10.3171/2021.2.SPINE202199

Source: Journal of Neurosurgery.Spine - August 13, 2021 Category: Neurosurgery Authors: Xuguang Chen Sheng-Fu L Lo Chetan Bettegowda Daniel M Ryan John M Gross Chen Hu Lawrence Kleinberg Daniel M Sciubba Kristin J Redmond Source Type: research